Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Esomeprazole potassium salt

Esomeprazole potassium salt

161796-84-5

DISCOVER
Ephedrine DRUG PRECURSOR

Ephedrine DRUG PRECURSOR

299-42-3

DISCOVER
PLASTIC ADDITIVE 04 CRS (500 MG)

PLASTIC ADDITIVE 04 CRS (500 MG)

08/07/8013

DISCOVER
EQUINE INFLUENZA SUBTYPE 1 STRAIN A/EQ/ NEWMARKET/ 77 H A BR

EQUINE INFLUENZA SUBTYPE 1 STRAIN A/EQ/ NEWMARKET/ 77 H A BR

NA

DISCOVER
EQUINE INFLUENZA SUBTYPE 2 AMERICAN-LIKE/NEWMARKET/1/93 H A

EQUINE INFLUENZA SUBTYPE 2 AMERICAN-LIKE/NEWMARKET/1/93 H A

NA

DISCOVER
EQUINE INFLUENZA SUBTYPE 2 EUROPEAN-LIKE/ NEWMARKET/2/93 H A

EQUINE INFLUENZA SUBTYPE 2 EUROPEAN-LIKE/ NEWMARKET/2/93 H A

NA

DISCOVER
Epinephrine (-)

Epinephrine (-)

51-43-4

DISCOVER
ERGOCALCIFEROL CRS (70 MG)

ERGOCALCIFEROL CRS (70 MG)

50-14-6

DISCOVER
Eplerenone 7-Carboxylic Acid

Eplerenone 7-Carboxylic Acid

209253-82-7

DISCOVER
Echimidine N-Oxide

Echimidine N-Oxide

41093-89-4

DISCOVER
ERGOMETRINE MALEATE CRS - * DRUG PRECURSOR (50 MG)

ERGOMETRINE MALEATE CRS - * DRUG PRECURSOR (50 MG)

129-51-1

DISCOVER
Ergometrine maleate - * prec CErgometrine maleate - * prec CErgometrine maleate - * prec C

Ergometrine maleate - * prec CErgometrine maleate - * prec CErgometrine maleate - * prec C

129-51-1

DISCOVER